Tuberculosis Clinical Intensive – Guam 2017
Course Directors: Stacey Rizza, M.D., Zelalem Temesgen, M.D., John Wilson, M.D., Richard Brostrom, M.D., M.S.P.H., Neha Shah, M.D., M.P.H.
Registration Fees: This course is free of charge.
This two day intensive course will familiarize the clinician with all the aspects of tuberculosis infection, disease and clinical care using an interdisciplinary and interactive approach. The curriculum is provided through lecture and interactive case management sessions. The faculty is selected for their unique skills in encouraging interaction and building rapport with participants. This is the first time Mayo Clinic Center for Tuberculosis has provided an educational activity in the United States Affiliated Pacific Islands Pacific Region (USAPI) in Guam.
Accommodations:
Pacific Star Resort
627B Pale San Vitores Rd.
Tumon, 96913 Guam
1-671-649-7827
Additional Information
Program Schedule (PDF)
Credit
This course is planned in collaboration with the Centers for Disease Control and Prevention, Curry International Tuberculosis Center, Heartland National TB Center, Mayo Clinic Center for Tuberculosis, Rutgers Global Tuberculosis Institute, and Southeastern National Tuberculosis Center.
For additional information visit: Mayo Clinic Center for Tuberculosis
Target Audience
This course is designed for physicians, nurses, pharmacists and other health care professionals, who are involved in the management of patients with tuberculosis (TB), supervise those who provide care for TB patients, or are TB control staff responsible for program management.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Apply current advances for assessing risk, testing and treating latent TB infection to prevent development of disease
- Apply recommendations for the diagnosis and treatment of TB disease to prevent transmission and primary drug resistance
- Identify appropriate TB infection control measures along the continuum of care to prevent transmission and future cases of TB
- Describe approaches for managing adverse drug effects to anti-TB medications to minimize toxicity and ensure completion of therapy
- Explain how primary care providers and community agencies can collaborate to prevent missed opportunities in the diagnosis and treatment of TB
- Describe the new Centers for Disease Control and Prevention TB Treatment and Prevention Guidelines
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Available Credit
- 13.25 ACPE
- 14.50 AMA PRA Category 1 Credit™
- 14.25 ANCC